Slater supports biopharma and biotech companies in their business development and commercialization strategy. He partners with companies focused on commercial assessments, business development and new product planning strategy, pipeline/portfolio prioritization and strategy, and launch roadmap planning, bringing deep experience in rare diseases. Clients leverage Slater’s insights in navigating early- to mid- clinical stage product development opportunities and the commercial needs required to recognize their full potential.
Prior to joining ClearView, Slater spent several years working in a translational hematology/oncology research lab in the Boston area. Slater holds a B.A. from Duke University and a M.S. from Boston University.
Debbi Amanti Belanger
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Dean Griffiths
Kim Goh
Slater Hurst
Ketan Kapadia
Philip Kenner
Jessica Lee
Stuart MacGregor
Charles Mathews
David McClain
Kai-Ming Pu
Richard Mynahan
Kevin Richard
Derek Riesenberg
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Michael Agne
Jonathan Betts
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Dave Konciak
Alexander Lehrman
Matthew Pfister
Olivia Piccione
Sarah Stapleton
Brian Quinn
Kelsey Yardumian
Jake Arakal
Kali Barnes
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Cem Salfati
Sam Smith
Jim Duffy
Lainey Miller
Melanie Robinson